Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker
Phase 4
Completed
- Conditions
- Hypertension
- Registration Number
- NCT00185120
- Lead Sponsor
- Daiichi Sankyo
- Brief Summary
A comparison of 2 different combinations of high blood pressure medications to treat hypertension
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 152
Inclusion Criteria
- Greater than 18 years of age
- Patients with high blood pressure
Exclusion Criteria
- Hypertensive encephalopathy, stroke or transient ischemic attack within the past 6 months
- History of myocardial infarction, percutaneous transluminal coronary revascularization, coronary artery bypass graft, and/or unstable angina pectoris within the past 6 months
- Type 1 diabetes mellitus
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Change in systolic blood pressure from the start of the study
- Secondary Outcome Measures
Name Time Method Change in diastolic blood pressure from the start of the study Percent of patients who achieve target blood pressure goals
Trial Locations
- Locations (19)
Memorial Research Medical Center
🇺🇸Long Beach, California, United States
National Research Institute
🇺🇸Los Angeles, California, United States
Clinical Trials Research
🇺🇸Roseville, California, United States
Apex Research Institute
🇺🇸Santa Ana, California, United States
Orange County Research Center
🇺🇸Tustin, California, United States
Westlake Medical Center
🇺🇸Westlake Village, California, United States
Clinical Research of South Florida
🇺🇸Coral Gables, Florida, United States
The Greater Fort Lauderdale Heart Group Research
🇺🇸Fort lauderdale, Florida, United States
SFBC International
🇺🇸Miami, Florida, United States
CLIRECO, Inc.
🇺🇸Tamarac, Florida, United States
Scroll for more (9 remaining)Memorial Research Medical Center🇺🇸Long Beach, California, United States